| pubmed-article:12094857 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12094857 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:12094857 | lifeskim:mentions | umls-concept:C0009324 | lld:lifeskim |
| pubmed-article:12094857 | lifeskim:mentions | umls-concept:C0013072 | lld:lifeskim |
| pubmed-article:12094857 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:12094857 | lifeskim:mentions | umls-concept:C0127615 | lld:lifeskim |
| pubmed-article:12094857 | lifeskim:mentions | umls-concept:C0205177 | lld:lifeskim |
| pubmed-article:12094857 | lifeskim:mentions | umls-concept:C0052940 | lld:lifeskim |
| pubmed-article:12094857 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:12094857 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:12094857 | pubmed:dateCreated | 2002-7-3 | lld:pubmed |
| pubmed-article:12094857 | pubmed:abstractText | Balsalazide is a new innovative, mesalamine-containing prodrug that is activated by bacteria in the colon. Balsalazide has been shown previously to be well tolerated and effective in the treatment of acute ulcerative colitis. The aim of this study was to determine the dose-response of balsalazide for efficacy and safety in active, mild-to-moderate ulcerative colitis and to compare this profile with that of mesalamine, pH-dependent, delayed-release tablets. | lld:pubmed |
| pubmed-article:12094857 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12094857 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12094857 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12094857 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12094857 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12094857 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12094857 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12094857 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12094857 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12094857 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12094857 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12094857 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12094857 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:12094857 | pubmed:issn | 0002-9270 | lld:pubmed |
| pubmed-article:12094857 | pubmed:author | pubmed-author:SalesDavidD | lld:pubmed |
| pubmed-article:12094857 | pubmed:author | pubmed-author:LevineDouglas... | lld:pubmed |
| pubmed-article:12094857 | pubmed:author | pubmed-author:RiffDennis... | lld:pubmed |
| pubmed-article:12094857 | pubmed:author | pubmed-author:PruittRonaldR | lld:pubmed |
| pubmed-article:12094857 | pubmed:author | pubmed-author:WrubleLawrenc... | lld:pubmed |
| pubmed-article:12094857 | pubmed:author | pubmed-author:KovalGeorgeG | lld:pubmed |
| pubmed-article:12094857 | pubmed:author | pubmed-author:BellJohn KJK | lld:pubmed |
| pubmed-article:12094857 | pubmed:author | pubmed-author:JohnsonLorin... | lld:pubmed |
| pubmed-article:12094857 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12094857 | pubmed:volume | 97 | lld:pubmed |
| pubmed-article:12094857 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12094857 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12094857 | pubmed:pagination | 1398-407 | lld:pubmed |
| pubmed-article:12094857 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12094857 | pubmed:meshHeading | pubmed-meshheading:12094857... | lld:pubmed |
| pubmed-article:12094857 | pubmed:meshHeading | pubmed-meshheading:12094857... | lld:pubmed |
| pubmed-article:12094857 | pubmed:meshHeading | pubmed-meshheading:12094857... | lld:pubmed |
| pubmed-article:12094857 | pubmed:meshHeading | pubmed-meshheading:12094857... | lld:pubmed |
| pubmed-article:12094857 | pubmed:meshHeading | pubmed-meshheading:12094857... | lld:pubmed |
| pubmed-article:12094857 | pubmed:meshHeading | pubmed-meshheading:12094857... | lld:pubmed |
| pubmed-article:12094857 | pubmed:meshHeading | pubmed-meshheading:12094857... | lld:pubmed |
| pubmed-article:12094857 | pubmed:meshHeading | pubmed-meshheading:12094857... | lld:pubmed |
| pubmed-article:12094857 | pubmed:meshHeading | pubmed-meshheading:12094857... | lld:pubmed |
| pubmed-article:12094857 | pubmed:meshHeading | pubmed-meshheading:12094857... | lld:pubmed |
| pubmed-article:12094857 | pubmed:meshHeading | pubmed-meshheading:12094857... | lld:pubmed |
| pubmed-article:12094857 | pubmed:meshHeading | pubmed-meshheading:12094857... | lld:pubmed |
| pubmed-article:12094857 | pubmed:meshHeading | pubmed-meshheading:12094857... | lld:pubmed |
| pubmed-article:12094857 | pubmed:meshHeading | pubmed-meshheading:12094857... | lld:pubmed |
| pubmed-article:12094857 | pubmed:meshHeading | pubmed-meshheading:12094857... | lld:pubmed |
| pubmed-article:12094857 | pubmed:meshHeading | pubmed-meshheading:12094857... | lld:pubmed |
| pubmed-article:12094857 | pubmed:meshHeading | pubmed-meshheading:12094857... | lld:pubmed |
| pubmed-article:12094857 | pubmed:meshHeading | pubmed-meshheading:12094857... | lld:pubmed |
| pubmed-article:12094857 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12094857 | pubmed:articleTitle | A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis. | lld:pubmed |
| pubmed-article:12094857 | pubmed:affiliation | Division of Gastroenterology, University of Washington School of Medicine, Seattle, USA. | lld:pubmed |
| pubmed-article:12094857 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12094857 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12094857 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:12094857 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:12094857 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12094857 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12094857 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12094857 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12094857 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12094857 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12094857 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12094857 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12094857 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12094857 | lld:pubmed |
